000 | 01900 a2200529 4500 | ||
---|---|---|---|
005 | 20250515172455.0 | ||
264 | 0 | _c20100204 | |
008 | 201002s 0 0 eng d | ||
022 | _a1873-3476 | ||
024 | 7 |
_a10.1016/j.ijpharm.2009.04.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOyarzun-Ampuero, F A | |
245 | 0 | 0 |
_aChitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. _h[electronic resource] |
260 |
_bInternational journal of pharmaceutics _cNov 2009 |
||
300 |
_a122-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 |
_aCell Degranulation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aChitosan _xchemistry |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aEndocytosis _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeparin _xadministration & dosage |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xchemistry |
650 | 0 | 4 |
_aHistamine Release _xdrug effects |
650 | 0 | 4 |
_aHyaluronic Acid _xchemistry |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 |
_aMast Cells _xpathology |
650 | 0 | 4 |
_aNanoparticles _xchemistry |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_ap-Methoxy-N-methylphenethylamine _xmetabolism |
700 | 1 | _aBrea, J | |
700 | 1 | _aLoza, M I | |
700 | 1 | _aTorres, D | |
700 | 1 | _aAlonso, M J | |
773 | 0 |
_tInternational journal of pharmaceutics _gvol. 381 _gno. 2 _gp. 122-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2009.04.009 _zAvailable from publisher's website |
999 |
_c18893657 _d18893657 |